RETA
Reata Pharmaceuticals Inc
Chief Research Officer Colin John Meyer sold $4.4M of Reata Pharmaceuticals Inc
Sold$4,375,000
$175.00Price
25,000Shares
−26%Stake
What RETA did after the filing
Prices for RETA after this filing aren't in yet.
Traded Mon, Nov 9. Filed Tue, Nov 10, 12:59 PM ET, during the session. Not investment advice.